Biomarkers of latent TB infection

作者: Morten Ruhwald , Pernille Ravn

DOI: 10.1586/ERS.09.31

关键词:

摘要: For the last 100 years, tuberculin skin test (TST) has been only diagnostic tool available for latent TB infection (LTBI) and no biomarker per se is to diagnose presence of LTBI. With introduction M. tuberculosis-specific IFN-gamma release assays (IGRAs), a new area in vitro immunodiagnostic tests LTBI based on readout become reality. In this review, we discuss existing evidence clinical usefulness IGRAs indefinite number potential biomarkers that can be used improve diagnosis infection. We also present early data suggesting monocyte-derived chemokine inducible protein-10 may useful as novel immunodiagnosis

参考文章(130)
Karen R Steingart, Megan Henry, Suman Laal, Philip C Hopewell, Andrew Ramsay, Dick Menzies, Jane Cunningham, Karin Weldingh, Madhukar Pai, Commercial Serological Antibody Detection Tests for the Diagnosis of Pulmonary Tuberculosis: A Systematic Review PLOS Medicine. ,vol. 4, ,(2007) , 10.1371/JOURNAL.PMED.0040202
P. Fitzgerald-Bocarsly, D. Feng, The role of type I interferon production by dendritic cells in host defense Biochimie. ,vol. 89, pp. 843- 855 ,(2007) , 10.1016/J.BIOCHI.2007.04.018
Morten Ruhwald, Morten Bjerregaard-Andersen, Paulo Rabna, Kristian Kofoed, Jesper Eugen-Olsen, Pernille Ravn, CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. Microbes and Infection. ,vol. 9, pp. 806- 812 ,(2007) , 10.1016/J.MICINF.2007.02.021
Bernadette M Saunders, Warwick J Britton, Life and death in the granuloma: immunopathology of tuberculosis. Immunology and Cell Biology. ,vol. 85, pp. 103- 111 ,(2007) , 10.1038/SJ.ICB.7100027
Annalisa Azzurri, Oumou Y. Sow, Amedeo Amedei, Boubacar Bah, Sadio Diallo, Giuseppe Peri, Marisa Benagiano, Mario M. D’Elios, Alberto Mantovani, Gianfranco Del Prete, IFN-γ-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection Microbes and Infection. ,vol. 7, pp. 1- 8 ,(2005) , 10.1016/J.MICINF.2004.09.004
Peter M Small, Mark D Perkins, More rigour needed in trials of new diagnostic agents for tuberculosis. The Lancet. ,vol. 356, pp. 1048- 1049 ,(2000) , 10.1016/S0140-6736(00)02724-0
Sandra A. Calarota, Miguel Otero, Keith Hermanstayne, Mark Lewis, Margherita Rosati, Barbara K. Felber, George N. Pavlakis, Jean D. Boyer, David B. Weiner, Use of interleukin 15 to enhance interferon-γ production by antigen-specific stimulated lymphocytes from rhesus macaques Journal of Immunological Methods. ,vol. 279, pp. 55- 67 ,(2003) , 10.1016/S0022-1759(03)00246-1
Liya Wassie, Abebech Demissie, Abraham Aseffa, Markos Abebe, Lawrence Yamuah, Hiwot Tilahun, Beyene Petros, Graham Rook, Alimuddin Zumla, Peter Andersen, T Mark Doherty, Chifumbe Chintu Gina Mulundu, Peter Mwaba, Ex Vivo Cytokine mRNA Levels Correlate with Changing Clinical Status of Ethiopian TB Patients and their Contacts Over Time PLoS ONE. ,vol. 3, pp. e1522- ,(2008) , 10.1371/JOURNAL.PONE.0001522
Jean-Louis Herrmann, Marie Belloy, Raphael Porcher, Nancy Simonney, Rola Aboutaam, Muriel Lebourgeois, Joel Gaudelus, Laure De LosAngeles, Katarina Chadelat, Pierre Scheinmann, Nicole Beydon, Brigitte Fauroux, Martine Bingen, Mustapha Terki, Dominique Barraud, Philippe Cruaud, Catherine Offredo, Agnes Ferroni, Patrick Berche, Didier Moissenet, Hoang Vuthien, Catherine Doit, Edouard Bingen, Philippe Henri Lagrange, Temporal dynamics of interferon gamma responses in children evaluated for tuberculosis. PLOS ONE. ,vol. 4, ,(2009) , 10.1371/JOURNAL.PONE.0004130